Literature DB >> 20177359

Should we try to eliminate HIV epidemics by using a 'Test and Treat' strategy?

Bradley G Wagner, James S Kahn, Sally Blower.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20177359      PMCID： PMC2895980          DOI： 10.1097/QAD.0b013e3283366782

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  9 in total

Review 1.  Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?

Authors:  J X Velasco-Hernandez; H B Gershengorn; S M Blower
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

2.  Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.

Authors:  Reuben M Granich; Charles F Gilks; Christopher Dye; Kevin M De Cock; Brian G Williams
Journal:  Lancet       Date:  2008-11-27       Impact factor: 79.321

3.  A tale of two futures: HIV and antiretroviral therapy in San Francisco.

Authors:  S M Blower; H B Gershengorn; R M Grant
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

4.  Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.

Authors:  Peter J Dodd; Geoff P Garnett; Timothy B Hallett
Journal:  AIDS       Date:  2010-03-13       Impact factor: 4.177

5.  Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.

Authors:  Stephen D Lawn; Landon Myer; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2006-08-01       Impact factor: 4.177

6.  When to start antiretroviral therapy in resource-limited settings.

Authors:  Rochelle P Walensky; Lindsey L Wolf; Robin Wood; Mariam O Fofana; Kenneth A Freedberg; Neil A Martinson; A David Paltiel; Xavier Anglaret; Milton C Weinstein; Elena Losina
Journal:  Ann Intern Med       Date:  2009-07-20       Impact factor: 25.391

7.  Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.

Authors:  Sean Emery; Jacqueline A Neuhaus; Andrew N Phillips; Abdel Babiker; Calvin J Cohen; Jose M Gatell; Pierre-Marie Girard; Birgit Grund; Matthew Law; Marcelo H Losso; Adrian Palfreeman; Robin Wood
Journal:  J Infect Dis       Date:  2008-04-15       Impact factor: 5.226

8.  Effect of early versus deferred antiretroviral therapy for HIV on survival.

Authors:  Mari M Kitahata; Stephen J Gange; Alison G Abraham; Barry Merriman; Michael S Saag; Amy C Justice; Robert S Hogg; Steven G Deeks; Joseph J Eron; John T Brooks; Sean B Rourke; M John Gill; Ronald J Bosch; Jeffrey N Martin; Marina B Klein; Lisa P Jacobson; Benigno Rodriguez; Timothy R Sterling; Gregory D Kirk; Sonia Napravnik; Anita R Rachlis; Liviana M Calzavara; Michael A Horberg; Michael J Silverberg; Kelly A Gebo; James J Goedert; Constance A Benson; Ann C Collier; Stephen E Van Rompaey; Heidi M Crane; Rosemary G McKaig; Bryan Lau; Aimee M Freeman; Richard D Moore
Journal:  N Engl J Med       Date:  2009-04-01       Impact factor: 91.245

Review 9.  Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

Authors:  Jonathan A C Sterne; Margaret May; Dominique Costagliola; Frank de Wolf; Andrew N Phillips; Ross Harris; Michele Jönsson Funk; Ronald B Geskus; John Gill; François Dabis; Jose M Miró; Amy C Justice; Bruno Ledergerber; Gerd Fätkenheuer; Robert S Hogg; Antonella D'Arminio Monforte; Michael Saag; Colette Smith; Schlomo Staszewski; Matthias Egger; Stephen R Cole
Journal:  Lancet       Date:  2009-04-08       Impact factor: 79.321
  9 in total
  28 in total

1.  Sexual HIV transmission and antiretroviral therapy: a prospective cohort study of behavioral risk factors among men and women living with HIV/AIDS.

Authors:  Seth C Kalichman; Chauncey Cherry; Denise White; Miche'l Jones; Tamar Grebler; Moira O Kalichman; Mervi Detorio; Angela M Caliendo; Raymond F Schinazi
Journal:  Ann Behav Med       Date:  2011-08

2.  Massive benefits of antiretroviral therapy in Africa.

Authors:  Sten H Vermund
Journal:  J Infect Dis       Date:  2013-12-03       Impact factor: 5.226

Review 3.  Clinical uncertainties, health service challenges, and ethical complexities of HIV "test-and-treat": a systematic review.

Authors:  Sonali P Kulkarni; Kavita R Shah; Karthik V Sarma; Anish P Mahajan
Journal:  Am J Public Health       Date:  2013-04-18       Impact factor: 9.308

4.  Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis.

Authors:  Nadia N Abuelezam; Alethea W McCormick; Thomas Fussell; Abena N Afriyie; Robin Wood; Victor DeGruttola; Kenneth A Freedberg; Marc Lipsitch; George R Seage
Journal:  Am J Epidemiol       Date:  2016-07-13       Impact factor: 4.897

5.  Responding to the National HIV/AIDS Strategy-setting the research agenda.

Authors:  Stephen F Morin; Jeffrey A Kelly; Edwin D Charlebois; Robert H Remien; Mary J Rotheram-Borus; Paul D Cleary
Journal:  J Acquir Immune Defic Syndr       Date:  2011-07-01       Impact factor: 3.731

6.  Meta-analysis of single-session behavioral interventions to prevent sexually transmitted infections: implications for bundling prevention packages.

Authors:  Lisa A Eaton; Tania B Huedo-Medina; Seth C Kalichman; Jennifer A Pellowski; Michael J Sagherian; Michelle Warren; Ami R Popat; Blair T Johnson
Journal:  Am J Public Health       Date:  2012-09-20       Impact factor: 9.308

7.  Antiretroviral therapy: a promising HIV prevention strategy?

Authors:  Wafaa M El-Sadr; Megan Affrunti; Theresa Gamble; Allison Zerbe
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

8.  Economics of antiretroviral treatment vs. circumcision for HIV prevention.

Authors:  Till Bärnighausen; David E Bloom; Salal Humair
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-06       Impact factor: 11.205

9.  Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South Africa.

Authors:  Carel Pretorius; John Stover; Lori Bollinger; Nicolas Bacaër; Brian Williams
Journal:  PLoS One       Date:  2010-11-05       Impact factor: 3.240

Review 10.  Modelling sexual transmission of HIV: testing the assumptions, validating the predictions.

Authors:  Rebecca F Baggaley; Christophe Fraser
Journal:  Curr Opin HIV AIDS       Date:  2010-07       Impact factor: 4.283
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.